Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 11:26 ET | Source: Research and Markets

Epilepsy Global Clinical Trials Market Review 2025: G7 & E7, Phase, Trial Status, End Points Status and Sponsor Type

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Epilepsy - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides...
November 03, 2025 08:30 ET | Source: NetraMark Holdings Inc.

Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights

TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is...
November 03, 2025 08:30 ET | Source: PharmAla Biotech

PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital

PharmAla files its final short form prospectus, and announces a signed term sheet with an R&D tax credit financing firm called Radium
November 03, 2025 06:10 ET | Source: Research and Markets

CD40 Targeted Therapies Opportunity Insights Report 2026-2027: Market is Emerging with Over 35 Therapies in Trials and is Driven by Technological Innovations and Global Collaborations

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches, Proprietary Technology Platforms & Market Opportunity Insight 2026" report has...
November 03, 2025 06:06 ET | Source: Research and Markets

Lung Cancer Antibody Drug Conjugates Research 2025: A $2 Billion Opportunity in 2030, Led by AstraZeneca, Daiichi Sankyo, Pfizer, and BMS Advancing Targeted Therapies Against HER2, TROP-2, and B7-H3

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Lung Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price & Clinical Trials Insight 2030" report has been added to ...
November 03, 2025 05:54 ET | Source: Research and Markets

Breast Cancer Antibody Drug Conjugates Market Research 2025-2030: $7 Billion Market Led by Daiichi Sankyo and AstraZeneca, with Rising Competition from Roche, Pfizer/Seagen, ADC Therapeutics

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added...
November 03, 2025 04:04 ET | Source: Research and Markets

EU Clinical Trial Regulation 536/2014: Compliance, Implementation & Best Practices Training (November 25, 2025)

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "EU Clinical Trial Regulation 536/2014: Compliance, Implementation & Best Practices Training (November 25, 2025)" training has been added to ...
November 03, 2025 03:00 ET | Source: Avance Clinical

Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna

Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna
October 31, 2025 05:11 ET | Source: Research and Markets

Hemophilia A (Factor VIII Deficiency) Global Clinical Trials Market Review 2025: Hemlibra Demonstrates Exercise-Related Bleeding Prevention as Pfizer Reports Positive Phase III BAISIS Trial Results

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
October 31, 2025 05:06 ET | Source: Research and Markets

Catalyst Monitor Outlook, Q4 2025 Report: Pipeline Advances with Key Approvals and Trials: Featuring Cytokinetics's Aficamten, Aldeyra's Reproxalap, GSK's Depemokimab

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Catalyst Monitor: Q4 2025 Outlook" report has been added to ResearchAndMarkets.com's offering.This report compiles published, predictive intelligence...